1. Home
  2. BNZI vs EVOK Comparison

BNZI vs EVOK Comparison

Compare BNZI & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNZI
  • EVOK
  • Stock Information
  • Founded
  • BNZI 2016
  • EVOK 2007
  • Country
  • BNZI United States
  • EVOK United States
  • Employees
  • BNZI N/A
  • EVOK N/A
  • Industry
  • BNZI
  • EVOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • BNZI
  • EVOK Health Care
  • Exchange
  • BNZI Nasdaq
  • EVOK Nasdaq
  • Market Cap
  • BNZI 8.9M
  • EVOK 7.1M
  • IPO Year
  • BNZI N/A
  • EVOK 2013
  • Fundamental
  • Price
  • BNZI $1.64
  • EVOK $5.37
  • Analyst Decision
  • BNZI Strong Buy
  • EVOK
  • Analyst Count
  • BNZI 1
  • EVOK 0
  • Target Price
  • BNZI $125.00
  • EVOK N/A
  • AVG Volume (30 Days)
  • BNZI 4.7M
  • EVOK 9.0K
  • Earning Date
  • BNZI 02-28-2025
  • EVOK 03-13-2025
  • Dividend Yield
  • BNZI N/A
  • EVOK N/A
  • EPS Growth
  • BNZI N/A
  • EVOK N/A
  • EPS
  • BNZI N/A
  • EVOK N/A
  • Revenue
  • BNZI $4,310,782.00
  • EVOK $8,617,036.00
  • Revenue This Year
  • BNZI $5.58
  • EVOK $97.35
  • Revenue Next Year
  • BNZI $58.87
  • EVOK $99.52
  • P/E Ratio
  • BNZI N/A
  • EVOK N/A
  • Revenue Growth
  • BNZI N/A
  • EVOK 100.35
  • 52 Week Low
  • BNZI $1.21
  • EVOK $3.54
  • 52 Week High
  • BNZI $67.65
  • EVOK $12.32
  • Technical
  • Relative Strength Index (RSI)
  • BNZI 50.20
  • EVOK 65.36
  • Support Level
  • BNZI $1.51
  • EVOK $4.68
  • Resistance Level
  • BNZI $1.74
  • EVOK $5.40
  • Average True Range (ATR)
  • BNZI 0.26
  • EVOK 0.33
  • MACD
  • BNZI -0.00
  • EVOK 0.07
  • Stochastic Oscillator
  • BNZI 27.40
  • EVOK 97.46

About BNZI Banzai International Inc.

Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling better marketing, sales and customer engagement outcomes. The company sells its products using a recurring subscription license model typical in SaaS businesses. Pricing tiers for its main product, Demio, are based on the number of host-capable users, desired feature sets, and maximum audience size.

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: